CD19-directed chimeric antigen receptor cell therapy for treating autoimmune and neurological diseases
TW202626100APending Publication Date: 2026-07-01JUNO THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114132730
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-28
- Filing Date
- 2025-08-27
- Publication Date
- 2026-07-01
Abstract
Provided herein are adoptive cell therapy methods and uses involving the administration of a dose of T cells expressing a CD19-directed chimeric antigen receptor for treating subjects with autoimmune and neurological disease and disorders and related methods, compositions, uses and articles of manufacture.
Need to check novelty before this filing date? Find Prior Art